DH
Vice President, Global Program Leader, Takeda Pharmaceuticals International, Inc.
Deborah Hartman is VP Global Program Leader in the Neuroscience Area at Takeda Pharmaceuticals in Cambridge, MA. Deborah leads early clinical development programs focused on new treatments for rare disease indications. Prior to Takeda, Deborah held R&D leadership roles at AstraZeneca...
Read More →
Senior Vice President, Center for Rare Diseases, PRA Health Sciences
Scott Schliebner is a clinical strategist with a 20+ year background in clinical development specializing in rare diseases and orphan drug development. His experience encompasses all trial phases; a broad variety of study designs; interventional and observational studies; across a...
Read More →
Director, Clinical Operations Lead, CSL Behring
I have been with CSL Behring for 6 years working & managing clinical trials in rare diseases. I currently lead the Immunology & Acq. Bleeding operations group CSL. I spent 12 years at Sanofi managing international studies, interacting with study sites and monitoring. I graduated with...
Read More →